Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Midatech Pharma plc
DescriptionImmunotherapy with a proinsulin-derived peptide using gold nanoparticle (GNP) technology
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today